Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1989 1
1990 1
1991 1
1995 1
1996 1
1998 3
1999 3
2000 4
2002 4
2003 3
2004 5
2005 10
2006 17
2007 20
2008 34
2009 64
2010 19
2011 12
2012 4
2013 5
2014 2
2015 3
2016 3
2017 9
2018 3
2019 5
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 19563434

227 results

Results by year

Filters applied: . Clear all
Page 1
Drug policy for visceral leishmaniasis: a cost-effectiveness analysis.
Vanlerberghe V, Diap G, Guerin PJ, Meheus F, Gerstl S, Van der Stuyft P, Boelaert M. Vanlerberghe V, et al. Trop Med Int Health. 2007 Feb;12(2):274-83. doi: 10.1111/j.1365-3156.2006.01782.x. Trop Med Int Health. 2007. PMID: 17300636 Free article.
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial.
Sundar S, Sinha PK, Rai M, Verma DK, Nawin K, Alam S, Chakravarty J, Vaillant M, Verma N, Pandey K, Kumari P, Lal CS, Arora R, Sharma B, Ellis S, Strub-Wourgaft N, Balasegaram M, Olliaro P, Das P, Modabber F. Sundar S, et al. Lancet. 2011 Feb 5;377(9764):477-86. doi: 10.1016/S0140-6736(10)62050-8. Epub 2011 Jan 20. Lancet. 2011. PMID: 21255828 Clinical Trial.
Drug combinations for visceral leishmaniasis.
Olliaro PL. Olliaro PL. Curr Opin Infect Dis. 2010 Dec;23(6):595-602. doi: 10.1097/QCO.0b013e32833fca9d. Curr Opin Infect Dis. 2010. PMID: 20871400 Review.
Injectable paromomycin for Visceral leishmaniasis in India.
Sundar S, Jha TK, Thakur CP, Sinha PK, Bhattacharya SK. Sundar S, et al. N Engl J Med. 2007 Jun 21;356(25):2571-81. doi: 10.1056/NEJMoa066536. N Engl J Med. 2007. PMID: 17582067 Free article. Clinical Trial.
Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh.
Rahman R, Goyal V, Haque R, Jamil K, Faiz A, Samad R, Ellis S, Balasegaram M, Boer MD, Rijal S, Strub-Wourgaft N, Alves F, Alvar J, Sharma B. Rahman R, et al. PLoS Negl Trop Dis. 2017 May 30;11(5):e0005635. doi: 10.1371/journal.pntd.0005635. eCollection 2017 May. PLoS Negl Trop Dis. 2017. PMID: 28558062 Free PMC article. Clinical Trial.
227 results